Circulating cell-free (plasma/serum) biomarkers include?nucleic acids, extracellular vesicles, proteins and metabolites from all metastatic sites?as well as normal organ physiologic turn over or impact of systemic drug treatment.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Circulating Biomarker industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Cell-Free DNA (cfDNA)
Extracellular Vesicles (EVs)
Others
Market Segment by Product Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring Orthopedics
Finally, the report provides detailed profile and data information analysis of leading company.
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Circulating Biomarker consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Circulating Biomarker market by identifying its various subsegments.
3.Focuses on the key global Circulating Biomarker manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Circulating Biomarker with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Circulating Biomarker submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Circulating Biomarker Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Circulating Biomarker Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Circulating Biomarker Segment by Type
2.1.1 Circulating Tumor Cells (CTCs)
2.1.2 Circulating Tumor DNA (ctDNA)
2.1.3 Cell-Free DNA (cfDNA)
2.1.4 Extracellular Vesicles (EVs)
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Early Cancer Screening
2.2.2 Therapy Selection
2.2.3 Treatment Monitoring
2.2.4 Recurrence Monitoring Orthopedics
2.3 Global Circulating Biomarker Market Comparison by Regions (2017-2027)
2.3.1 Global Circulating Biomarker Market Size (2017-2027)
2.3.2 North America Circulating Biomarker Status and Prospect (2017-2027)
2.3.3 Europe Circulating Biomarker Status and Prospect (2017-2027)
2.3.4 China Circulating Biomarker Status and Prospect (2017-2027)
2.3.5 Japan Circulating Biomarker Status and Prospect (2017-2027)
2.3.6 Southeast Asia Circulating Biomarker Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Circulating Biomarker Industry Impact
2.5.1 Circulating Biomarker Business Impact Assessment - Covid-19
2.5.2 Market Trends and Circulating Biomarker Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Circulating Biomarker Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Circulating Biomarker Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Circulating Biomarker Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Circulating Biomarker Manufacturer Market Share
3.5 Top 10 Circulating Biomarker Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Circulating Biomarker Market
3.7 Key Manufacturers Circulating Biomarker Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Circulating Biomarker Industry Key Manufacturers
4.1 Abbott Laboratories
4.1.1 Compan Detail
4.1.2 Abbott Laboratories Circulating Biomarker Product Introduction, Application and Specification
4.1.3 Abbott Laboratories 131 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Abbott Laboratories News
4.2 Becton, Dickinson and Company
4.2.1 Compan Detail
4.2.2 Becton, Dickinson and Company Circulating Biomarker Product Introduction, Application and Specification
4.2.3 Becton, Dickinson and Company Circulating Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Abbott Laboratories News
4.3 GE Healthcare
4.3.1 Compan Detail
4.3.2 GE Healthcare Circulating Biomarker Product Introduction, Application and Specification
4.3.3 GE Healthcare Circulating Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 GE Healthcare News
4.4 Epigenomics AG
4.4.1 Compan Detail
4.4.2 Epigenomics AG Circulating Biomarker Product Introduction, Application and Specification
4.4.3 Epigenomics AG Circulating Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Epigenomics AG News
4.5 Agilent Technologies
4.5.1 Compan Detail
4.5.2 Epigenomics AG Circulating Biomarker Product Introduction, Application and Specification
4.5.3 Agilent Technologies Circulating Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Agilent Technologies News
4.6 Biocept
4.6.1 Compan Detail
4.6.2 Biocept Circulating Biomarker Product Introduction, Application and Specification
4.6.3 Biocept Circulating Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Biocept News
4.7 Affymetrix
4.7.1 Compan Detail
4.7.2 Affymetrix Circulating Biomarker Product Introduction, Application and Specification
4.7.3 Affymetrix Circulating Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Fluxion Biosciences
4.8.1 Compan Detail
4.8.2 Fluxion Biosciences Circulating Biomarker Product Introduction, Application and Specification
4.8.3 Fluxion Biosciences Circulating Biomarker Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Fluxion Biosciences News
5 Global Circulating Biomarker Market Segment by Big Type
5.1 Global Circulating Biomarker Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Circulating Biomarker Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Circulating Biomarker Revenue and Market Share by Big Type (2017-2022)
5.2 Circulating Tumor Cells (CTCs) Sales Growth Rate and Price
5.2.1 Global Circulating Tumor Cells (CTCs) Sales Growth Rate (2017-2022)
5.2.2 Global Circulating Tumor Cells (CTCs) Price (2017-2022)
5.3 Circulating Tumor DNA (ctDNA) Sales Growth Rate and Price
5.3.1 Global Circulating Tumor DNA (ctDNA) Sales Growth Rate (2017-2022)
5.3.2 Global Circulating Tumor DNA (ctDNA) Price (2017-2022)
5.4 Cell-Free DNA (cfDNA) Sales Growth Rate and Price
5.4.1 Global Cell-Free DNA (cfDNA) Sales Growth Rate (2017-2022)
5.4.2 Global Cell-Free DNA (cfDNA) Price (2017-2022)
5.5 Extracellular Vesicles (EVs) Sales Growth Rate and Price
5.5.1 Global Extracellular Vesicles (EVs) Sales Growth Rate (2017-2022)
5.5.2 Global Extracellular Vesicles (EVs) Price (2017-2022)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2017-2022)
5.6.2 Global Others Price (2017-2022)
6 Global Circulating Biomarker Market Segment by Big Application
6.1 Global Circulating Biomarker Sales Market Share by Big Application (2017-2022)
6.2 Early Cancer Screening Sales Growth Rate (2017-2022)
6.3 Therapy Selection Sales Growth Rate (2017-2022)
6.4 Treatment Monitoring Sales Growth Rate (2017-2022)
6.5 Recurrence Monitoring Orthopedics Sales Growth Rate (2017-2022)
7 Global Circulating Biomarker Forecast
7.1 Global Circulating Biomarker Revenue, Sales and Growth Rate (2022-2027)
7.2 Circulating Biomarker Market Forecast by Regions (2022-2027)
7.2.1 North America Circulating Biomarker Market Forecast (2022-2027)
7.2.2 Europe Circulating Biomarker Market Forecast (2022-2027)
7.2.3 China Circulating Biomarker Market Forecast (2022-2027)
7.2.4 Japan Circulating Biomarker Market Forecast (2022-2027)
7.2.5 Southeast Asia Circulating Biomarker Market Forecast (2022-2027)
7.2.6 Other Regions Circulating Biomarker Market Forecast (2022-2027)
7.3 Circulating Biomarker Market Forecast by Type (2022-2027)
7.3.1 Global Circulating Biomarker Sales Forecast by Type (2022-2027)
7.3.2 Global Circulating Biomarker Market Share Forecast by Type (2022-2027)
7.4 Circulating Biomarker Market Forecast by Application (2022-2027)
7.4.1 Global Circulating Biomarker Sales Forecast by Application (2022-2027)
7.4.2 Global Circulating Biomarker Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Circulating Biomarker Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Circulating Biomarker Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Circulating Biomarker
Figure Market Concentration Ratio and Market Maturity Analysis of Circulating Biomarker
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Circulating Biomarker Market Size by Big Type
Figure Global Market Share of Circulating Biomarker by Big Type in 2021
Figure Circulating Tumor Cells (CTCs) Picture (2017-2022)
Figure Circulating Tumor DNA (ctDNA) Picture (2017-2022)
Figure Cell-Free DNA (cfDNA) Picture (2017-2022)
Figure Extracellular Vesicles (EVs) Picture (2017-2022)
Global Circulating Biomarker Market Size by Big Application
Table Global Circulating Biomarker Market Size by Application
Figure Global Circulating Biomarker Market Share by Big Application in 2021
Figure Early Cancer Screening Picture
Figure Therapy Selection Picture
Figure Treatment Monitoring Picture
Figure Recurrence Monitoring Orthopedics Picture
Table Global Circulating Biomarker Comparison by Regions (M USD) (2017-2027)
Figure Global Circulating Biomarker Market Size (Million US$) (2017-2027)
Figure North America Circulating Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Circulating Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure China Circulating Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Circulating Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Circulating Biomarker Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Circulating Biomarker Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Circulating Biomarker Sales by Manufacturer (2017-2022)
Figure Global Circulating Biomarker Sales Market Share by Manufacturer in 2021
Table Global Circulating Biomarker Revenue by Manufacturer (2017-2022)
Figure Global Circulating Biomarker Revenue Market Share by Manufacturer in 2021
Table Global Circulating Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Circulating Biomarker Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Circulating Biomarker Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Circulating Biomarker Market
Table Key Manufacturers Circulating Biomarker Product Type
Table Mergers & Acquisitions Planning
Table Abbott Laboratories Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of Abbott Laboratories
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Becton, Dickinson and Company Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of Becton, Dickinson and Company
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Becton, Dickinson and Company Recent Development
Table GE Healthcare Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of GE Healthcare
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GE Healthcare Main Business
Table GE Healthcare Recent Development
Table Epigenomics AG Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of Epigenomics AG
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Epigenomics AG Main Business
Table Epigenomics AG Recent Development
Table Epigenomics AG Main Business
Table Epigenomics AG Recent Development
Table Agilent Technologies Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of Agilent Technologies
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Agilent Technologies Main Business
Table Agilent Technologies Recent Development
Table Biocept Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of Biocept
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biocept Main Business
Table Biocept Recent Development
Table Affymetrix Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of Affymetrix
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Affymetrix Main Business
Table Affymetrix Recent Development
Table Fluxion Biosciences Company Profile
Table Circulating Biomarker Product Introduction, Application and Specification of Fluxion Biosciences
Table Circulating Biomarker Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Fluxion Biosciences Main Business
Table Fluxion Biosciences Recent Development
Figure Global Circulating Biomarker Sales and Growth Rate (2017-2022)
Figure Global Circulating Biomarker Revenue and Growth Rate (2017-2022)
Table Global Circulating Biomarker Sales by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Market Share by Regions in 2021
Table Global Circulating Biomarker Revenue by Regions (2017-2022)
Figure Global Circulating Biomarker Revenue Market Share by Regions in 2021
Figure North America Circulating Biomarker Sales and Growth Rate (2017-2022)
Figure Europe Circulating Biomarker Sales and Growth Rate (2017-2022)
Figure China Circulating Biomarker Sales and Growth Rate (2017-2022)
Figure Japan Circulating Biomarker Sales and Growth Rate (2017-2022)
Figure Southeast Asia Circulating Biomarker Sales and Growth Rate (2017-2022)
Figure Other Regions Circulating Biomarker Sales and Growth Rate (2017-2022)
Table Global Circulating Biomarker Sales by Big Type (2017-2022)
Table Global Circulating Biomarker Sales Market Share by Big Type (2017-2022)
Figure Global Circulating Biomarker Sales Market Share by Big Type in 2019
Table Global Circulating Biomarker Revenue by Big Type (2017-2022)
Table Global Circulating Biomarker Revenue Market Share by Big Type (2017-2022)
Table Global Circulating Biomarker Revenue Market Share by Big Type in 2019
Figure Global Circulating Tumor Cells (CTCs) Sales Growth Rate (2017-2022)
Figure Global Circulating Tumor Cells (CTCs) Price (2017-2022)
Figure Global Circulating Tumor DNA (ctDNA) Sales Growth Rate (2017-2022)
Figure Global Circulating Tumor DNA (ctDNA) Price (2017-2022)
Figure Global Cell-Free DNA (cfDNA) Sales Growth Rate (2017-2022)
Figure Global Cell-Free DNA (cfDNA) Price (2017-2022)
Figure Global Extracellular Vesicles (EVs) Sales Growth Rate (2017-2022)
Figure Global Extracellular Vesicles (EVs) Price (2017-2022)
Table Global Circulating Biomarker Sales by Big Application (2017-2022)
Table Global Circulating Biomarker Sales Market Share by Big Application (2017-2022)
Figure Global Circulating Biomarker Sales Market Share by Big Application in 2019
Figure Global Early Cancer Screening Sales Growth Rate (2017-2022)
Figure Global Therapy Selection Sales Growth Rate (2017-2022)
Figure Global Treatment Monitoring Sales Growth Rate (2017-2022)
Figure Global Recurrence Monitoring Orthopedics Sales Growth Rate (2017-2022)
Figure Global Circulating Biomarker Sales and Growth Rate (2022-2027)
Figure Global Circulating Biomarker Revenue and Growth Rate (2022-2027)
Table Global Circulating Biomarker Sales Forecast by Regions (2022-2027)
Table Global Circulating Biomarker Market Share Forecast by Regions (2022-2027)
Figure North America Sales Circulating Biomarker Market Forecast (2022-2027)
Figure Europe Sales Circulating Biomarker Market Forecast (2022-2027)
Figure China Sales Circulating Biomarker Market Forecast (2022-2027)
Figure Japan Sales Circulating Biomarker Market Forecast (2022-2027)
Figure Southeast Asia Sales Circulating Biomarker Market Forecast (2022-2027)
Figure Other Regions Sales Circulating Biomarker Market Forecast (2022-2027)
Table Global Circulating Biomarker Sales Forecast by Type (2022-2027)
Table Global Circulating Biomarker Market Share Forecast by Type (2022-2027)
Table Global Circulating Biomarker Sales Forecast by Application (2022-2027)
Table Global Circulating Biomarker Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Circulating Biomarker
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Circulating Biomarker Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Circulating Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Circulating Biomarker Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Circulating Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Circulating Biomarker Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Circulating Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Circulating Biomarker Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Circulating Biomarker Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)